nodes	percent_of_prediction	percent_of_DWPC	metapath
Floxuridine—TYMS—breast cancer	0.264	1	CbGaD
Floxuridine—TYMP—Capecitabine—breast cancer	0.138	0.335	CbGbCtD
Floxuridine—Decitabine—Gemcitabine—breast cancer	0.137	1	CrCrCtD
Floxuridine—TYMP—Fluorouracil—breast cancer	0.082	0.199	CbGbCtD
Floxuridine—TYMS—Capecitabine—breast cancer	0.0736	0.178	CbGbCtD
Floxuridine—TYMS—Gemcitabine—breast cancer	0.051	0.124	CbGbCtD
Floxuridine—TYMS—Fluorouracil—breast cancer	0.0436	0.106	CbGbCtD
Floxuridine—TYMS—Methotrexate—breast cancer	0.0241	0.0583	CbGbCtD
Floxuridine—TYMP—mammary gland—breast cancer	0.00221	0.111	CbGeAlD
Floxuridine—TYMP—nipple—breast cancer	0.00182	0.0919	CbGeAlD
Floxuridine—Stavudine—SLC28A1—breast cancer	0.00138	0.398	CrCbGaD
Floxuridine—TYMP—endometrium—breast cancer	0.0011	0.0555	CbGeAlD
Floxuridine—TYMP—uterus—breast cancer	0.00102	0.0511	CbGeAlD
Floxuridine—TYMS—skin of body—breast cancer	0.001	0.0505	CbGeAlD
Floxuridine—TYMP—pituitary gland—breast cancer	0.000997	0.0502	CbGeAlD
Floxuridine—TYMP—adipose tissue—breast cancer	0.000993	0.05	CbGeAlD
Floxuridine—TYMS—endometrium—breast cancer	0.000945	0.0476	CbGeAlD
Floxuridine—TYMP—female reproductive system—breast cancer	0.000913	0.046	CbGeAlD
Floxuridine—TYMP—adrenal gland—breast cancer	0.000891	0.0449	CbGeAlD
Floxuridine—TYMP—bone marrow—breast cancer	0.000862	0.0434	CbGeAlD
Floxuridine—TYMS—adipose tissue—breast cancer	0.000852	0.0429	CbGeAlD
Floxuridine—TYMP—female gonad—breast cancer	0.000831	0.0418	CbGeAlD
Floxuridine—TYMS—female reproductive system—breast cancer	0.000783	0.0394	CbGeAlD
Floxuridine—TYMP—endocrine gland—breast cancer	0.000772	0.0389	CbGeAlD
Floxuridine—TYMS—adrenal gland—breast cancer	0.000764	0.0385	CbGeAlD
Floxuridine—TYMS—bone marrow—breast cancer	0.000739	0.0372	CbGeAlD
Floxuridine—TYMS—female gonad—breast cancer	0.000713	0.0359	CbGeAlD
Floxuridine—TYMS—endocrine gland—breast cancer	0.000663	0.0334	CbGeAlD
Floxuridine—Zidovudine—SLC28A1—breast cancer	0.000549	0.159	CrCbGaD
Floxuridine—Decitabine—DNMT3A—breast cancer	0.000544	0.157	CrCbGaD
Floxuridine—TYMP—lymph node—breast cancer	0.000534	0.0269	CbGeAlD
Floxuridine—TYMS—Docetaxel—Paclitaxel—breast cancer	0.000492	0.226	CbGdCrCtD
Floxuridine—TYMS—Gefitinib—Lapatinib—breast cancer	0.000482	0.222	CbGdCrCtD
Floxuridine—TYMS—lymph node—breast cancer	0.000458	0.0231	CbGeAlD
Floxuridine—Decitabine—DNMT1—breast cancer	0.000294	0.0849	CrCbGaD
Floxuridine—Zidovudine—TERT—breast cancer	0.000281	0.0811	CrCbGaD
Floxuridine—TYMS—Paclitaxel—Docetaxel—breast cancer	0.000246	0.113	CbGdCrCtD
Floxuridine—Trifluridine—TYMS—breast cancer	0.000191	0.055	CrCbGaD
Floxuridine—TYMS—Vincristine—Vinorelbine—breast cancer	0.000169	0.0775	CbGdCrCtD
Floxuridine—TYMS—Vinorelbine—Vinblastine—breast cancer	0.000158	0.0725	CbGdCrCtD
Floxuridine—TYMS—Vinblastine—Vinorelbine—breast cancer	0.000136	0.0623	CbGdCrCtD
Floxuridine—TYMS—Vincristine—Vinblastine—breast cancer	0.000135	0.062	CbGdCrCtD
Floxuridine—TYMS—Clobetasol propionate—Fluoxymesterone—breast cancer	0.000109	0.0499	CbGdCrCtD
Floxuridine—TYMS—Triamcinolone—Fluoxymesterone—breast cancer	0.000106	0.0487	CbGdCrCtD
Floxuridine—TYMS—Danazol—Fluoxymesterone—breast cancer	8.22e-05	0.0377	CbGdCrCtD
Floxuridine—Zidovudine—ABCG2—breast cancer	7.36e-05	0.0212	CrCbGaD
Floxuridine—TYMS—Azacitidine—Gemcitabine—breast cancer	6.36e-05	0.0292	CbGdCrCtD
Floxuridine—Cladribine—ABCG2—breast cancer	5.18e-05	0.015	CrCbGaD
Floxuridine—TYMP—Metabolism—BRIP1—breast cancer	4.88e-05	0.000792	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—LDHB—breast cancer	4.88e-05	0.000792	CbGpPWpGaD
Floxuridine—Dermatitis—Melphalan—breast cancer	4.85e-05	0.000487	CcSEcCtD
Floxuridine—TYMS—Mitotic G1-G1/S phases—RB1—breast cancer	4.83e-05	0.000785	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—HIST1H2BK—breast cancer	4.83e-05	0.000784	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—HIST1H2BC—breast cancer	4.83e-05	0.000784	CbGpPWpGaD
Floxuridine—Asthenia—Vinorelbine—breast cancer	4.82e-05	0.000484	CcSEcCtD
Floxuridine—Dry skin—Epirubicin—breast cancer	4.82e-05	0.000484	CcSEcCtD
Floxuridine—Decreased appetite—Mitoxantrone—breast cancer	4.82e-05	0.000484	CcSEcCtD
Floxuridine—Decreased appetite—Irinotecan—breast cancer	4.82e-05	0.000484	CcSEcCtD
Floxuridine—Nausea—Vinblastine—breast cancer	4.81e-05	0.000483	CcSEcCtD
Floxuridine—Vomiting—Goserelin—breast cancer	4.77e-05	0.000479	CcSEcCtD
Floxuridine—Alopecia—Docetaxel—breast cancer	4.77e-05	0.000479	CcSEcCtD
Floxuridine—Rash—Goserelin—breast cancer	4.73e-05	0.000475	CcSEcCtD
Floxuridine—Hypersensitivity—Thiotepa—breast cancer	4.73e-05	0.000475	CcSEcCtD
Floxuridine—Dermatitis—Goserelin—breast cancer	4.73e-05	0.000475	CcSEcCtD
Floxuridine—TYMS—E2F transcription factor network—MYC—breast cancer	4.71e-05	0.000765	CbGpPWpGaD
Floxuridine—Headache—Goserelin—breast cancer	4.7e-05	0.000472	CcSEcCtD
Floxuridine—Erythema—Docetaxel—breast cancer	4.7e-05	0.000472	CcSEcCtD
Floxuridine—Decreased appetite—Gemcitabine—breast cancer	4.7e-05	0.000471	CcSEcCtD
Floxuridine—Nausea—Tamoxifen—breast cancer	4.67e-05	0.000469	CcSEcCtD
Floxuridine—Discomfort—Paclitaxel—breast cancer	4.66e-05	0.000468	CcSEcCtD
Floxuridine—Gastritis—Epirubicin—breast cancer	4.66e-05	0.000467	CcSEcCtD
Floxuridine—TYMP—Metabolism—HMMR—breast cancer	4.62e-05	0.000751	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—GSTA3—breast cancer	4.62e-05	0.000751	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—ABCC1—breast cancer	4.62e-05	0.000751	CbGpPWpGaD
Floxuridine—Decreased appetite—Fluorouracil—breast cancer	4.62e-05	0.000464	CcSEcCtD
Floxuridine—Alopecia—Capecitabine—breast cancer	4.62e-05	0.000463	CcSEcCtD
Floxuridine—Pancytopenia—Methotrexate—breast cancer	4.61e-05	0.000463	CcSEcCtD
Floxuridine—Asthenia—Thiotepa—breast cancer	4.61e-05	0.000463	CcSEcCtD
Floxuridine—Diarrhoea—Vinorelbine—breast cancer	4.6e-05	0.000462	CcSEcCtD
Floxuridine—Nausea—Melphalan—breast cancer	4.57e-05	0.000459	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—FGFR1—breast cancer	4.57e-05	0.000742	CbGpPWpGaD
Floxuridine—Feeling abnormal—Irinotecan—breast cancer	4.57e-05	0.000459	CcSEcCtD
Floxuridine—Feeling abnormal—Mitoxantrone—breast cancer	4.57e-05	0.000459	CcSEcCtD
Floxuridine—Confusional state—Paclitaxel—breast cancer	4.56e-05	0.000458	CcSEcCtD
Floxuridine—Erythema—Capecitabine—breast cancer	4.55e-05	0.000457	CcSEcCtD
Floxuridine—Gastrointestinal pain—Mitoxantrone—breast cancer	4.53e-05	0.000455	CcSEcCtD
Floxuridine—Gastrointestinal pain—Irinotecan—breast cancer	4.53e-05	0.000455	CcSEcCtD
Floxuridine—Anaphylactic shock—Paclitaxel—breast cancer	4.52e-05	0.000454	CcSEcCtD
Floxuridine—Muscle spasms—Docetaxel—breast cancer	4.52e-05	0.000453	CcSEcCtD
Floxuridine—Infection—Paclitaxel—breast cancer	4.49e-05	0.000451	CcSEcCtD
Floxuridine—TYMS—Cell Cycle—FOXM1—breast cancer	4.49e-05	0.000729	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—PPARGC1B—breast cancer	4.48e-05	0.000727	CbGpPWpGaD
Floxuridine—TYMS—G1/S Transition—CDKN1B—breast cancer	4.47e-05	0.000725	CbGpPWpGaD
Floxuridine—Dry skin—Doxorubicin—breast cancer	4.46e-05	0.000448	CcSEcCtD
Floxuridine—Nausea—Goserelin—breast cancer	4.46e-05	0.000448	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—CDK2—breast cancer	4.46e-05	0.000724	CbGpPWpGaD
Floxuridine—Feeling abnormal—Gemcitabine—breast cancer	4.45e-05	0.000447	CcSEcCtD
Floxuridine—Nervous system disorder—Paclitaxel—breast cancer	4.43e-05	0.000445	CcSEcCtD
Floxuridine—Photosensitivity reaction—Methotrexate—breast cancer	4.43e-05	0.000445	CcSEcCtD
Floxuridine—Angina pectoris—Epirubicin—breast cancer	4.43e-05	0.000445	CcSEcCtD
Floxuridine—TYMS—Metabolism—SYNJ2—breast cancer	4.43e-05	0.000719	CbGpPWpGaD
Floxuridine—Thrombocytopenia—Paclitaxel—breast cancer	4.43e-05	0.000445	CcSEcCtD
Floxuridine—Diarrhoea—Thiotepa—breast cancer	4.39e-05	0.000441	CcSEcCtD
Floxuridine—Body temperature increased—Mitoxantrone—breast cancer	4.38e-05	0.00044	CcSEcCtD
Floxuridine—Abdominal pain—Mitoxantrone—breast cancer	4.38e-05	0.00044	CcSEcCtD
Floxuridine—Abdominal pain—Irinotecan—breast cancer	4.38e-05	0.00044	CcSEcCtD
Floxuridine—Body temperature increased—Irinotecan—breast cancer	4.38e-05	0.00044	CcSEcCtD
Floxuridine—Feeling abnormal—Fluorouracil—breast cancer	4.38e-05	0.000439	CcSEcCtD
Floxuridine—Muscle spasms—Capecitabine—breast cancer	4.37e-05	0.000439	CcSEcCtD
Floxuridine—Anaemia—Docetaxel—breast cancer	4.34e-05	0.000436	CcSEcCtD
Floxuridine—TYMS—Cell Cycle—HIST1H2BC—breast cancer	4.32e-05	0.000701	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—HIST1H2BK—breast cancer	4.32e-05	0.000701	CbGpPWpGaD
Floxuridine—Pancytopenia—Epirubicin—breast cancer	4.32e-05	0.000434	CcSEcCtD
Floxuridine—Anorexia—Paclitaxel—breast cancer	4.31e-05	0.000433	CcSEcCtD
Floxuridine—Gastritis—Doxorubicin—breast cancer	4.31e-05	0.000433	CcSEcCtD
Floxuridine—Vomiting—Vinorelbine—breast cancer	4.27e-05	0.000429	CcSEcCtD
Floxuridine—Body temperature increased—Gemcitabine—breast cancer	4.27e-05	0.000429	CcSEcCtD
Floxuridine—Rash—Vinorelbine—breast cancer	4.24e-05	0.000426	CcSEcCtD
Floxuridine—Dermatitis—Vinorelbine—breast cancer	4.23e-05	0.000425	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—ATM—breast cancer	4.23e-05	0.000687	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—CA9—breast cancer	4.23e-05	0.000687	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—GSTA4—breast cancer	4.23e-05	0.000687	CbGpPWpGaD
Floxuridine—Stomatitis—Methotrexate—breast cancer	4.22e-05	0.000424	CcSEcCtD
Floxuridine—Ill-defined disorder—Capecitabine—breast cancer	4.22e-05	0.000424	CcSEcCtD
Floxuridine—TYMS—Circadian rythm related genes—LEP—breast cancer	4.22e-05	0.000685	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—CDK4—breast cancer	4.21e-05	0.000684	CbGpPWpGaD
Floxuridine—Headache—Vinorelbine—breast cancer	4.21e-05	0.000423	CcSEcCtD
Floxuridine—Leukopenia—Docetaxel—breast cancer	4.2e-05	0.000422	CcSEcCtD
Floxuridine—Anaemia—Capecitabine—breast cancer	4.2e-05	0.000422	CcSEcCtD
Floxuridine—Body temperature increased—Fluorouracil—breast cancer	4.2e-05	0.000422	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—ESR1—breast cancer	4.19e-05	0.000681	CbGpPWpGaD
Floxuridine—Photosensitivity reaction—Epirubicin—breast cancer	4.15e-05	0.000417	CcSEcCtD
Floxuridine—TYMS—G1/S Transition—CDKN1A—breast cancer	4.12e-05	0.000669	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—GPX2—breast cancer	4.12e-05	0.000669	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—GSTA2—breast cancer	4.12e-05	0.000669	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—NDUFS3—breast cancer	4.12e-05	0.000669	CbGpPWpGaD
Floxuridine—Malaise—Capecitabine—breast cancer	4.1e-05	0.000412	CcSEcCtD
Floxuridine—Angina pectoris—Doxorubicin—breast cancer	4.1e-05	0.000411	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—NFKBIA—breast cancer	4.09e-05	0.000665	CbGpPWpGaD
Floxuridine—TYMS—Retinoblastoma (RB) in Cancer—MYC—breast cancer	4.09e-05	0.000665	CbGpPWpGaD
Floxuridine—Epistaxis—Methotrexate—breast cancer	4.09e-05	0.00041	CcSEcCtD
Floxuridine—Hypersensitivity—Mitoxantrone—breast cancer	4.09e-05	0.00041	CcSEcCtD
Floxuridine—Hypersensitivity—Irinotecan—breast cancer	4.09e-05	0.00041	CcSEcCtD
Floxuridine—Vomiting—Thiotepa—breast cancer	4.08e-05	0.00041	CcSEcCtD
Floxuridine—Leukopenia—Capecitabine—breast cancer	4.07e-05	0.000409	CcSEcCtD
Floxuridine—TYMP—Metabolism—SULT1A1—breast cancer	4.07e-05	0.000661	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—GPX4—breast cancer	4.07e-05	0.000661	CbGpPWpGaD
Floxuridine—Rash—Thiotepa—breast cancer	4.05e-05	0.000407	CcSEcCtD
Floxuridine—Dermatitis—Thiotepa—breast cancer	4.04e-05	0.000406	CcSEcCtD
Floxuridine—TYMS—Circadian rythm related genes—CDK4—breast cancer	4.04e-05	0.000657	CbGpPWpGaD
Floxuridine—Agranulocytosis—Methotrexate—breast cancer	4.04e-05	0.000406	CcSEcCtD
Floxuridine—Headache—Thiotepa—breast cancer	4.02e-05	0.000404	CcSEcCtD
Floxuridine—Pancytopenia—Doxorubicin—breast cancer	3.99e-05	0.000401	CcSEcCtD
Floxuridine—Nausea—Vinorelbine—breast cancer	3.99e-05	0.000401	CcSEcCtD
Floxuridine—Asthenia—Irinotecan—breast cancer	3.98e-05	0.000399	CcSEcCtD
Floxuridine—Asthenia—Mitoxantrone—breast cancer	3.98e-05	0.000399	CcSEcCtD
Floxuridine—TYMP—Metabolism—IDH1—breast cancer	3.97e-05	0.000645	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—GSTA1—breast cancer	3.97e-05	0.000645	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—APC—breast cancer	3.96e-05	0.000644	CbGpPWpGaD
Floxuridine—Stomatitis—Epirubicin—breast cancer	3.95e-05	0.000397	CcSEcCtD
Floxuridine—Decreased appetite—Paclitaxel—breast cancer	3.93e-05	0.000395	CcSEcCtD
Floxuridine—TYMP—Metabolism—NAT2—breast cancer	3.93e-05	0.000638	CbGpPWpGaD
Floxuridine—TYMS—Circadian rythm related genes—NOS2—breast cancer	3.93e-05	0.000638	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—EGF—breast cancer	3.92e-05	0.000636	CbGpPWpGaD
Floxuridine—Hypersensitivity—Fluorouracil—breast cancer	3.91e-05	0.000393	CcSEcCtD
Floxuridine—Haemoglobin—Methotrexate—breast cancer	3.91e-05	0.000392	CcSEcCtD
Floxuridine—TYMS—Cell Cycle—RAD51—breast cancer	3.89e-05	0.000632	CbGpPWpGaD
Floxuridine—Haemorrhage—Methotrexate—breast cancer	3.89e-05	0.00039	CcSEcCtD
Floxuridine—Asthenia—Gemcitabine—breast cancer	3.88e-05	0.000389	CcSEcCtD
Floxuridine—TYMS—Metabolism—CHST9—breast cancer	3.87e-05	0.000629	CbGpPWpGaD
Floxuridine—Confusional state—Docetaxel—breast cancer	3.86e-05	0.000388	CcSEcCtD
Floxuridine—Pharyngitis—Methotrexate—breast cancer	3.86e-05	0.000388	CcSEcCtD
Floxuridine—Photosensitivity reaction—Doxorubicin—breast cancer	3.84e-05	0.000386	CcSEcCtD
Floxuridine—Anaphylactic shock—Docetaxel—breast cancer	3.83e-05	0.000385	CcSEcCtD
Floxuridine—Discomfort—Capecitabine—breast cancer	3.82e-05	0.000384	CcSEcCtD
Floxuridine—Epistaxis—Epirubicin—breast cancer	3.82e-05	0.000384	CcSEcCtD
Floxuridine—Nausea—Thiotepa—breast cancer	3.81e-05	0.000383	CcSEcCtD
Floxuridine—Infection—Docetaxel—breast cancer	3.81e-05	0.000382	CcSEcCtD
Floxuridine—TYMS—Cell Cycle, Mitotic—TOP2A—breast cancer	3.8e-05	0.000618	CbGpPWpGaD
Floxuridine—Diarrhoea—Mitoxantrone—breast cancer	3.79e-05	0.000381	CcSEcCtD
Floxuridine—Diarrhoea—Irinotecan—breast cancer	3.79e-05	0.000381	CcSEcCtD
Floxuridine—Agranulocytosis—Epirubicin—breast cancer	3.78e-05	0.00038	CcSEcCtD
Floxuridine—TYMS—Mitotic G1-G1/S phases—CDKN1B—breast cancer	3.76e-05	0.000611	CbGpPWpGaD
Floxuridine—Nervous system disorder—Docetaxel—breast cancer	3.76e-05	0.000377	CcSEcCtD
Floxuridine—Thrombocytopenia—Docetaxel—breast cancer	3.75e-05	0.000377	CcSEcCtD
Floxuridine—Confusional state—Capecitabine—breast cancer	3.74e-05	0.000376	CcSEcCtD
Floxuridine—Feeling abnormal—Paclitaxel—breast cancer	3.73e-05	0.000374	CcSEcCtD
Floxuridine—Gastrointestinal pain—Paclitaxel—breast cancer	3.7e-05	0.000371	CcSEcCtD
Floxuridine—Diarrhoea—Gemcitabine—breast cancer	3.7e-05	0.000371	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—CASP8—breast cancer	3.69e-05	0.0006	CbGpPWpGaD
Floxuridine—Infection—Capecitabine—breast cancer	3.69e-05	0.00037	CcSEcCtD
Floxuridine—Zidovudine—CYP3A4—breast cancer	3.68e-05	0.0106	CrCbGaD
Floxuridine—TYMS—Metabolism—COX11—breast cancer	3.67e-05	0.000596	CbGpPWpGaD
Floxuridine—Haemoglobin—Epirubicin—breast cancer	3.66e-05	0.000367	CcSEcCtD
Floxuridine—Stomatitis—Doxorubicin—breast cancer	3.66e-05	0.000367	CcSEcCtD
Floxuridine—Anorexia—Docetaxel—breast cancer	3.65e-05	0.000367	CcSEcCtD
Floxuridine—Nervous system disorder—Capecitabine—breast cancer	3.64e-05	0.000365	CcSEcCtD
Floxuridine—Haemorrhage—Epirubicin—breast cancer	3.64e-05	0.000365	CcSEcCtD
Floxuridine—Diarrhoea—Fluorouracil—breast cancer	3.63e-05	0.000365	CcSEcCtD
Floxuridine—Thrombocytopenia—Capecitabine—breast cancer	3.63e-05	0.000365	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—IGF1—breast cancer	3.63e-05	0.00059	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—AURKA—breast cancer	3.63e-05	0.000589	CbGpPWpGaD
Floxuridine—Pharyngitis—Epirubicin—breast cancer	3.61e-05	0.000363	CcSEcCtD
Floxuridine—TYMS—Cell Cycle—NBN—breast cancer	3.61e-05	0.000586	CbGpPWpGaD
Floxuridine—TYMS—Mitotic G1-G1/S phases—CCND1—breast cancer	3.59e-05	0.000583	CbGpPWpGaD
Floxuridine—Abdominal pain—Paclitaxel—breast cancer	3.57e-05	0.000359	CcSEcCtD
Floxuridine—Body temperature increased—Paclitaxel—breast cancer	3.57e-05	0.000359	CcSEcCtD
Floxuridine—Epistaxis—Doxorubicin—breast cancer	3.54e-05	0.000355	CcSEcCtD
Floxuridine—Anorexia—Capecitabine—breast cancer	3.54e-05	0.000355	CcSEcCtD
Floxuridine—Vomiting—Irinotecan—breast cancer	3.53e-05	0.000354	CcSEcCtD
Floxuridine—Vomiting—Mitoxantrone—breast cancer	3.53e-05	0.000354	CcSEcCtD
Floxuridine—Agranulocytosis—Doxorubicin—breast cancer	3.5e-05	0.000351	CcSEcCtD
Floxuridine—Rash—Mitoxantrone—breast cancer	3.5e-05	0.000351	CcSEcCtD
Floxuridine—Rash—Irinotecan—breast cancer	3.5e-05	0.000351	CcSEcCtD
Floxuridine—Dermatitis—Mitoxantrone—breast cancer	3.49e-05	0.000351	CcSEcCtD
Floxuridine—Dermatitis—Irinotecan—breast cancer	3.49e-05	0.000351	CcSEcCtD
Floxuridine—Headache—Irinotecan—breast cancer	3.47e-05	0.000349	CcSEcCtD
Floxuridine—Headache—Mitoxantrone—breast cancer	3.47e-05	0.000349	CcSEcCtD
Floxuridine—TYMS—Mitotic G1-G1/S phases—CDKN1A—breast cancer	3.47e-05	0.000564	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—DPYD—breast cancer	3.45e-05	0.00056	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—MED12—breast cancer	3.45e-05	0.00056	CbGpPWpGaD
Floxuridine—Alopecia—Methotrexate—breast cancer	3.44e-05	0.000345	CcSEcCtD
Floxuridine—Vomiting—Gemcitabine—breast cancer	3.43e-05	0.000345	CcSEcCtD
Floxuridine—TYMS—G1/S Transition—MYC—breast cancer	3.42e-05	0.000555	CbGpPWpGaD
Floxuridine—Rash—Gemcitabine—breast cancer	3.41e-05	0.000342	CcSEcCtD
Floxuridine—Dermatitis—Gemcitabine—breast cancer	3.4e-05	0.000342	CcSEcCtD
Floxuridine—TYMS—Cell Cycle—TOP2A—breast cancer	3.4e-05	0.000552	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—ALDOA—breast cancer	3.39e-05	0.000551	CbGpPWpGaD
Floxuridine—Erythema—Methotrexate—breast cancer	3.38e-05	0.00034	CcSEcCtD
Floxuridine—Haemoglobin—Doxorubicin—breast cancer	3.38e-05	0.00034	CcSEcCtD
Floxuridine—Headache—Gemcitabine—breast cancer	3.38e-05	0.00034	CcSEcCtD
Floxuridine—Vomiting—Fluorouracil—breast cancer	3.38e-05	0.000339	CcSEcCtD
Floxuridine—Haemorrhage—Doxorubicin—breast cancer	3.37e-05	0.000338	CcSEcCtD
Floxuridine—TYMS—Retinoblastoma (RB) in Cancer—TP53—breast cancer	3.36e-05	0.000546	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—CDA—breast cancer	3.36e-05	0.000545	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—SHMT1—breast cancer	3.36e-05	0.000545	CbGpPWpGaD
Floxuridine—Rash—Fluorouracil—breast cancer	3.35e-05	0.000336	CcSEcCtD
Floxuridine—Dermatitis—Fluorouracil—breast cancer	3.35e-05	0.000336	CcSEcCtD
Floxuridine—Pharyngitis—Doxorubicin—breast cancer	3.34e-05	0.000336	CcSEcCtD
Floxuridine—Decreased appetite—Docetaxel—breast cancer	3.33e-05	0.000335	CcSEcCtD
Floxuridine—Hypersensitivity—Paclitaxel—breast cancer	3.33e-05	0.000335	CcSEcCtD
Floxuridine—Headache—Fluorouracil—breast cancer	3.33e-05	0.000334	CcSEcCtD
Floxuridine—TYMS—Circadian rythm related genes—SERPINE1—breast cancer	3.31e-05	0.000537	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—NCOA3—breast cancer	3.29e-05	0.000535	CbGpPWpGaD
Floxuridine—Nausea—Irinotecan—breast cancer	3.29e-05	0.000331	CcSEcCtD
Floxuridine—Nausea—Mitoxantrone—breast cancer	3.29e-05	0.000331	CcSEcCtD
Floxuridine—TYMP—Metabolism—SLC2A2—breast cancer	3.27e-05	0.000531	CbGpPWpGaD
Floxuridine—Asthenia—Paclitaxel—breast cancer	3.24e-05	0.000326	CcSEcCtD
Floxuridine—TYMS—Cell Cycle—AURKA—breast cancer	3.24e-05	0.000527	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—SLCO1B1—breast cancer	3.23e-05	0.000525	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—SLC2A5—breast cancer	3.23e-05	0.000525	CbGpPWpGaD
Floxuridine—Decreased appetite—Capecitabine—breast cancer	3.23e-05	0.000324	CcSEcCtD
Floxuridine—Alopecia—Epirubicin—breast cancer	3.22e-05	0.000323	CcSEcCtD
Floxuridine—Zidovudine—ALB—breast cancer	3.21e-05	0.00927	CrCbGaD
Floxuridine—Nausea—Gemcitabine—breast cancer	3.21e-05	0.000322	CcSEcCtD
Floxuridine—TYMP—Metabolism—CPT1A—breast cancer	3.2e-05	0.00052	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—ABCG2—breast cancer	3.2e-05	0.00052	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—MTR—breast cancer	3.2e-05	0.00052	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—HSP90AA1—breast cancer	3.17e-05	0.000515	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—BCL2—breast cancer	3.17e-05	0.000515	CbGpPWpGaD
Floxuridine—Erythema—Epirubicin—breast cancer	3.17e-05	0.000318	CcSEcCtD
Floxuridine—Feeling abnormal—Docetaxel—breast cancer	3.16e-05	0.000317	CcSEcCtD
Floxuridine—Nausea—Fluorouracil—breast cancer	3.15e-05	0.000317	CcSEcCtD
Floxuridine—TYMP—Metabolism—HPGDS—breast cancer	3.14e-05	0.00051	CbGpPWpGaD
Floxuridine—Ill-defined disorder—Methotrexate—breast cancer	3.14e-05	0.000315	CcSEcCtD
Floxuridine—Gastrointestinal pain—Docetaxel—breast cancer	3.13e-05	0.000315	CcSEcCtD
Floxuridine—Anaemia—Methotrexate—breast cancer	3.13e-05	0.000314	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—MDM2—breast cancer	3.12e-05	0.000507	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—HBA1—breast cancer	3.12e-05	0.000507	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—APRT—breast cancer	3.12e-05	0.000507	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—RAF1—breast cancer	3.11e-05	0.000505	CbGpPWpGaD
Floxuridine—Diarrhoea—Paclitaxel—breast cancer	3.09e-05	0.000311	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—ERBB2—breast cancer	3.08e-05	0.0005	CbGpPWpGaD
Floxuridine—Zidovudine—ABCB1—breast cancer	3.06e-05	0.00884	CrCbGaD
Floxuridine—Feeling abnormal—Capecitabine—breast cancer	3.06e-05	0.000307	CcSEcCtD
Floxuridine—Malaise—Methotrexate—breast cancer	3.05e-05	0.000307	CcSEcCtD
Floxuridine—TYMP—Metabolism—GSTT1—breast cancer	3.05e-05	0.000495	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—ACHE—breast cancer	3.05e-05	0.000495	CbGpPWpGaD
Floxuridine—Muscle spasms—Epirubicin—breast cancer	3.05e-05	0.000306	CcSEcCtD
Floxuridine—Gastrointestinal pain—Capecitabine—breast cancer	3.03e-05	0.000305	CcSEcCtD
Floxuridine—Abdominal pain—Docetaxel—breast cancer	3.03e-05	0.000304	CcSEcCtD
Floxuridine—Body temperature increased—Docetaxel—breast cancer	3.03e-05	0.000304	CcSEcCtD
Floxuridine—Leukopenia—Methotrexate—breast cancer	3.03e-05	0.000304	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—PTGS2—breast cancer	3.01e-05	0.000489	CbGpPWpGaD
Floxuridine—Alopecia—Doxorubicin—breast cancer	2.98e-05	0.000299	CcSEcCtD
Floxuridine—Ill-defined disorder—Epirubicin—breast cancer	2.94e-05	0.000295	CcSEcCtD
Floxuridine—Abdominal pain—Capecitabine—breast cancer	2.93e-05	0.000295	CcSEcCtD
Floxuridine—Body temperature increased—Capecitabine—breast cancer	2.93e-05	0.000295	CcSEcCtD
Floxuridine—TYMS—Metabolism—ESRRA—breast cancer	2.93e-05	0.000476	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—ANGPTL4—breast cancer	2.93e-05	0.000476	CbGpPWpGaD
Floxuridine—Erythema—Doxorubicin—breast cancer	2.93e-05	0.000294	CcSEcCtD
Floxuridine—Anaemia—Epirubicin—breast cancer	2.93e-05	0.000294	CcSEcCtD
Floxuridine—TYMS—Cell Cycle—CHEK2—breast cancer	2.9e-05	0.000471	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—CYP17A1—breast cancer	2.88e-05	0.000468	CbGpPWpGaD
Floxuridine—TYMS—Mitotic G1-G1/S phases—MYC—breast cancer	2.88e-05	0.000468	CbGpPWpGaD
Floxuridine—Vomiting—Paclitaxel—breast cancer	2.88e-05	0.000289	CcSEcCtD
Floxuridine—Malaise—Epirubicin—breast cancer	2.86e-05	0.000287	CcSEcCtD
Floxuridine—TYMP—Metabolism—PTGS1—breast cancer	2.86e-05	0.000464	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—ENO1—breast cancer	2.86e-05	0.000464	CbGpPWpGaD
Floxuridine—Rash—Paclitaxel—breast cancer	2.85e-05	0.000286	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1B—breast cancer	2.85e-05	0.000463	CbGpPWpGaD
Floxuridine—Dermatitis—Paclitaxel—breast cancer	2.85e-05	0.000286	CcSEcCtD
Floxuridine—Discomfort—Methotrexate—breast cancer	2.85e-05	0.000286	CcSEcCtD
Floxuridine—Leukopenia—Epirubicin—breast cancer	2.84e-05	0.000285	CcSEcCtD
Floxuridine—TYMS—Cell Cycle—HSP90AA1—breast cancer	2.84e-05	0.00046	CbGpPWpGaD
Floxuridine—Headache—Paclitaxel—breast cancer	2.83e-05	0.000284	CcSEcCtD
Floxuridine—Hypersensitivity—Docetaxel—breast cancer	2.82e-05	0.000284	CcSEcCtD
Floxuridine—Muscle spasms—Doxorubicin—breast cancer	2.82e-05	0.000283	CcSEcCtD
Floxuridine—TYMP—Metabolism—CYP2D6—breast cancer	2.8e-05	0.000455	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—CASP3—breast cancer	2.79e-05	0.000454	CbGpPWpGaD
Floxuridine—Confusional state—Methotrexate—breast cancer	2.79e-05	0.00028	CcSEcCtD
Floxuridine—TYMS—Metabolism—HADHB—breast cancer	2.78e-05	0.000452	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—GPI—breast cancer	2.78e-05	0.000452	CbGpPWpGaD
Floxuridine—Anaphylactic shock—Methotrexate—breast cancer	2.76e-05	0.000277	CcSEcCtD
Floxuridine—Asthenia—Docetaxel—breast cancer	2.75e-05	0.000276	CcSEcCtD
Floxuridine—TYMP—Metabolism—NCOA2—breast cancer	2.75e-05	0.000446	CbGpPWpGaD
Floxuridine—Infection—Methotrexate—breast cancer	2.74e-05	0.000276	CcSEcCtD
Floxuridine—Hypersensitivity—Capecitabine—breast cancer	2.73e-05	0.000275	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—CCND1—breast cancer	2.72e-05	0.000442	CbGpPWpGaD
Floxuridine—Ill-defined disorder—Doxorubicin—breast cancer	2.72e-05	0.000273	CcSEcCtD
Floxuridine—TYMS—Cell Cycle—BRCA1—breast cancer	2.72e-05	0.000441	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—JUN—breast cancer	2.71e-05	0.000441	CbGpPWpGaD
Floxuridine—Nervous system disorder—Methotrexate—breast cancer	2.71e-05	0.000272	CcSEcCtD
Floxuridine—Anaemia—Doxorubicin—breast cancer	2.71e-05	0.000272	CcSEcCtD
Floxuridine—Thrombocytopenia—Methotrexate—breast cancer	2.7e-05	0.000272	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—CTNNB1—breast cancer	2.69e-05	0.000437	CbGpPWpGaD
Floxuridine—Nausea—Paclitaxel—breast cancer	2.69e-05	0.00027	CcSEcCtD
Floxuridine—TYMP—Metabolism—FASN—breast cancer	2.67e-05	0.000433	CbGpPWpGaD
Floxuridine—Discomfort—Epirubicin—breast cancer	2.66e-05	0.000268	CcSEcCtD
Floxuridine—TYMS—Cell Cycle, Mitotic—CCNE1—breast cancer	2.66e-05	0.000432	CbGpPWpGaD
Floxuridine—Asthenia—Capecitabine—breast cancer	2.66e-05	0.000267	CcSEcCtD
Floxuridine—TYMP—Metabolism—BCHE—breast cancer	2.65e-05	0.000431	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—ALDH1A1—breast cancer	2.65e-05	0.000431	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—ALDH7A1—breast cancer	2.65e-05	0.000431	CbGpPWpGaD
Floxuridine—Malaise—Doxorubicin—breast cancer	2.64e-05	0.000265	CcSEcCtD
Floxuridine—Anorexia—Methotrexate—breast cancer	2.63e-05	0.000264	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1A—breast cancer	2.63e-05	0.000427	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—PTEN—breast cancer	2.63e-05	0.000426	CbGpPWpGaD
Floxuridine—Leukopenia—Doxorubicin—breast cancer	2.62e-05	0.000263	CcSEcCtD
Floxuridine—Diarrhoea—Docetaxel—breast cancer	2.62e-05	0.000263	CcSEcCtD
Floxuridine—TYMP—Metabolism—SLC5A5—breast cancer	2.62e-05	0.000426	CbGpPWpGaD
Floxuridine—Confusional state—Epirubicin—breast cancer	2.61e-05	0.000262	CcSEcCtD
Floxuridine—TYMS—Circadian rythm related genes—JUN—breast cancer	2.61e-05	0.000423	CbGpPWpGaD
Floxuridine—Anaphylactic shock—Epirubicin—breast cancer	2.59e-05	0.00026	CcSEcCtD
Floxuridine—Infection—Epirubicin—breast cancer	2.57e-05	0.000258	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—MAPK8—breast cancer	2.57e-05	0.000417	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—PHGDH—breast cancer	2.54e-05	0.000413	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—ADSL—breast cancer	2.54e-05	0.000413	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—NME1—breast cancer	2.54e-05	0.000413	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—FHL2—breast cancer	2.54e-05	0.000413	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—UMPS—breast cancer	2.54e-05	0.000413	CbGpPWpGaD
Floxuridine—Diarrhoea—Capecitabine—breast cancer	2.54e-05	0.000255	CcSEcCtD
Floxuridine—Nervous system disorder—Epirubicin—breast cancer	2.54e-05	0.000255	CcSEcCtD
Floxuridine—TYMP—Metabolism—SLC2A1—breast cancer	2.53e-05	0.000411	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—NQO1—breast cancer	2.53e-05	0.000411	CbGpPWpGaD
Floxuridine—Thrombocytopenia—Epirubicin—breast cancer	2.53e-05	0.000254	CcSEcCtD
Floxuridine—TYMS—Circadian rythm related genes—PTEN—breast cancer	2.52e-05	0.000409	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—H2AFX—breast cancer	2.52e-05	0.000409	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—E2F1—breast cancer	2.5e-05	0.000406	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—LDHB—breast cancer	2.49e-05	0.000405	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—HPSE—breast cancer	2.49e-05	0.000405	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—BRIP1—breast cancer	2.49e-05	0.000405	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—CYP3A4—breast cancer	2.47e-05	0.000401	CbGpPWpGaD
Floxuridine—Discomfort—Doxorubicin—breast cancer	2.47e-05	0.000248	CcSEcCtD
Floxuridine—TYMS—Circadian rythm related genes—MAPK8—breast cancer	2.47e-05	0.0004	CbGpPWpGaD
Floxuridine—Anorexia—Epirubicin—breast cancer	2.46e-05	0.000247	CcSEcCtD
Floxuridine—TYMS—Cell Cycle—BRCA2—breast cancer	2.46e-05	0.000399	CbGpPWpGaD
Floxuridine—Vomiting—Docetaxel—breast cancer	2.44e-05	0.000245	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—SRC—breast cancer	2.43e-05	0.000395	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—CYP1B1—breast cancer	2.43e-05	0.000394	CbGpPWpGaD
Floxuridine—Rash—Docetaxel—breast cancer	2.42e-05	0.000243	CcSEcCtD
Floxuridine—Dermatitis—Docetaxel—breast cancer	2.41e-05	0.000242	CcSEcCtD
Floxuridine—Confusional state—Doxorubicin—breast cancer	2.41e-05	0.000242	CcSEcCtD
Floxuridine—Decreased appetite—Methotrexate—breast cancer	2.4e-05	0.000241	CcSEcCtD
Floxuridine—Headache—Docetaxel—breast cancer	2.4e-05	0.000241	CcSEcCtD
Floxuridine—Anaphylactic shock—Doxorubicin—breast cancer	2.39e-05	0.00024	CcSEcCtD
Floxuridine—TYMP—Metabolism—HSP90AA1—breast cancer	2.38e-05	0.000387	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—CCNE1—breast cancer	2.38e-05	0.000387	CbGpPWpGaD
Floxuridine—Infection—Doxorubicin—breast cancer	2.38e-05	0.000239	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—breast cancer	2.37e-05	0.000385	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—GSTA3—breast cancer	2.36e-05	0.000384	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—ABCC1—breast cancer	2.36e-05	0.000384	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—HMMR—breast cancer	2.36e-05	0.000384	CbGpPWpGaD
Floxuridine—Vomiting—Capecitabine—breast cancer	2.36e-05	0.000237	CcSEcCtD
Floxuridine—TYMS—Cell Cycle, Mitotic—BIRC5—breast cancer	2.35e-05	0.000382	CbGpPWpGaD
Floxuridine—Nervous system disorder—Doxorubicin—breast cancer	2.35e-05	0.000236	CcSEcCtD
Floxuridine—Thrombocytopenia—Doxorubicin—breast cancer	2.34e-05	0.000235	CcSEcCtD
Floxuridine—Rash—Capecitabine—breast cancer	2.34e-05	0.000235	CcSEcCtD
Floxuridine—Dermatitis—Capecitabine—breast cancer	2.34e-05	0.000235	CcSEcCtD
Floxuridine—Headache—Capecitabine—breast cancer	2.32e-05	0.000233	CcSEcCtD
Floxuridine—TYMP—Metabolism—NCOA1—breast cancer	2.32e-05	0.000376	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—PPARGC1B—breast cancer	2.29e-05	0.000372	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—STK11—breast cancer	2.28e-05	0.000371	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—CYP19A1—breast cancer	2.28e-05	0.000371	CbGpPWpGaD
Floxuridine—Anorexia—Doxorubicin—breast cancer	2.28e-05	0.000229	CcSEcCtD
Floxuridine—Nausea—Docetaxel—breast cancer	2.28e-05	0.000229	CcSEcCtD
Floxuridine—Feeling abnormal—Methotrexate—breast cancer	2.28e-05	0.000229	CcSEcCtD
Floxuridine—Gastrointestinal pain—Methotrexate—breast cancer	2.26e-05	0.000227	CcSEcCtD
Floxuridine—TYMS—Cell Cycle—H2AFX—breast cancer	2.25e-05	0.000366	CbGpPWpGaD
Floxuridine—Decreased appetite—Epirubicin—breast cancer	2.25e-05	0.000226	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—MAPK3—breast cancer	2.24e-05	0.000364	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—E2F1—breast cancer	2.24e-05	0.000363	CbGpPWpGaD
Floxuridine—Nausea—Capecitabine—breast cancer	2.2e-05	0.000221	CcSEcCtD
Floxuridine—Abdominal pain—Methotrexate—breast cancer	2.18e-05	0.000219	CcSEcCtD
Floxuridine—Body temperature increased—Methotrexate—breast cancer	2.18e-05	0.000219	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—MYC—breast cancer	2.18e-05	0.000354	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—TGFB1—breast cancer	2.18e-05	0.000353	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—GSTA4—breast cancer	2.16e-05	0.000351	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—CA9—breast cancer	2.16e-05	0.000351	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—CDK2—breast cancer	2.16e-05	0.00035	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—EGFR—breast cancer	2.13e-05	0.000347	CbGpPWpGaD
Floxuridine—Feeling abnormal—Epirubicin—breast cancer	2.13e-05	0.000214	CcSEcCtD
Floxuridine—TYMP—Metabolism—COMT—breast cancer	2.12e-05	0.000345	CbGpPWpGaD
Floxuridine—Gastrointestinal pain—Epirubicin—breast cancer	2.11e-05	0.000212	CcSEcCtD
Floxuridine—TYMP—Metabolism—GSTP1—breast cancer	2.11e-05	0.000343	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—GSTA2—breast cancer	2.11e-05	0.000342	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—GPX2—breast cancer	2.11e-05	0.000342	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—BIRC5—breast cancer	2.1e-05	0.000341	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—HMOX1—breast cancer	2.08e-05	0.000338	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—GPX4—breast cancer	2.08e-05	0.000338	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—SULT1A1—breast cancer	2.08e-05	0.000338	CbGpPWpGaD
Floxuridine—Decreased appetite—Doxorubicin—breast cancer	2.08e-05	0.000209	CcSEcCtD
Floxuridine—TYMP—Metabolism—ITPR1—breast cancer	2.08e-05	0.000338	CbGpPWpGaD
Floxuridine—Body temperature increased—Epirubicin—breast cancer	2.04e-05	0.000205	CcSEcCtD
Floxuridine—Abdominal pain—Epirubicin—breast cancer	2.04e-05	0.000205	CcSEcCtD
Floxuridine—TYMS—Cell Cycle, Mitotic—CDK4—breast cancer	2.04e-05	0.000331	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—TERT—breast cancer	2.04e-05	0.000331	CbGpPWpGaD
Floxuridine—Hypersensitivity—Methotrexate—breast cancer	2.04e-05	0.000204	CcSEcCtD
Floxuridine—TYMS—Metabolism—GSTA1—breast cancer	2.03e-05	0.00033	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—IDH1—breast cancer	2.03e-05	0.00033	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—TNF—breast cancer	2.03e-05	0.00033	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—KRAS—breast cancer	2.02e-05	0.000327	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—NAT2—breast cancer	2.01e-05	0.000326	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—ABCB1—breast cancer	2e-05	0.000325	CbGpPWpGaD
Floxuridine—Asthenia—Methotrexate—breast cancer	1.98e-05	0.000199	CcSEcCtD
Floxuridine—Feeling abnormal—Doxorubicin—breast cancer	1.97e-05	0.000198	CcSEcCtD
Floxuridine—TYMP—Metabolism—TYMS—breast cancer	1.96e-05	0.000319	CbGpPWpGaD
Floxuridine—Gastrointestinal pain—Doxorubicin—breast cancer	1.96e-05	0.000196	CcSEcCtD
Floxuridine—TYMP—Metabolism—NCOR1—breast cancer	1.94e-05	0.000315	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—GSTM1—breast cancer	1.94e-05	0.000315	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—PLA2G4A—breast cancer	1.94e-05	0.000315	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—CDK2—breast cancer	1.93e-05	0.000313	CbGpPWpGaD
Floxuridine—Hypersensitivity—Epirubicin—breast cancer	1.9e-05	0.000191	CcSEcCtD
Floxuridine—Abdominal pain—Doxorubicin—breast cancer	1.89e-05	0.00019	CcSEcCtD
Floxuridine—Body temperature increased—Doxorubicin—breast cancer	1.89e-05	0.00019	CcSEcCtD
Floxuridine—Diarrhoea—Methotrexate—breast cancer	1.89e-05	0.00019	CcSEcCtD
Floxuridine—TYMP—Metabolism—GPX1—breast cancer	1.86e-05	0.000302	CbGpPWpGaD
Floxuridine—Asthenia—Epirubicin—breast cancer	1.85e-05	0.000186	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—PIK3CA—breast cancer	1.85e-05	0.000301	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—CYP1A1—breast cancer	1.84e-05	0.000299	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—ATM—breast cancer	1.83e-05	0.000297	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—ERCC2—breast cancer	1.82e-05	0.000296	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—CDK4—breast cancer	1.82e-05	0.000296	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—TP53—breast cancer	1.79e-05	0.000291	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—RB1—breast cancer	1.77e-05	0.000288	CbGpPWpGaD
Floxuridine—Diarrhoea—Epirubicin—breast cancer	1.77e-05	0.000178	CcSEcCtD
Floxuridine—TYMS—Metabolism—MED12—breast cancer	1.76e-05	0.000286	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—DPYD—breast cancer	1.76e-05	0.000286	CbGpPWpGaD
Floxuridine—Hypersensitivity—Doxorubicin—breast cancer	1.76e-05	0.000177	CcSEcCtD
Floxuridine—Vomiting—Methotrexate—breast cancer	1.76e-05	0.000176	CcSEcCtD
Floxuridine—Rash—Methotrexate—breast cancer	1.74e-05	0.000175	CcSEcCtD
Floxuridine—Dermatitis—Methotrexate—breast cancer	1.74e-05	0.000175	CcSEcCtD
Floxuridine—TYMS—Metabolism—ALDOA—breast cancer	1.74e-05	0.000282	CbGpPWpGaD
Floxuridine—Headache—Methotrexate—breast cancer	1.73e-05	0.000174	CcSEcCtD
Floxuridine—TYMS—Circadian rythm related genes—TP53—breast cancer	1.72e-05	0.000279	CbGpPWpGaD
Floxuridine—Asthenia—Doxorubicin—breast cancer	1.72e-05	0.000172	CcSEcCtD
Floxuridine—TYMP—Metabolism—MTHFR—breast cancer	1.72e-05	0.000279	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—NCOA3—breast cancer	1.68e-05	0.000274	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—SLC2A2—breast cancer	1.67e-05	0.000272	CbGpPWpGaD
Floxuridine—Vomiting—Epirubicin—breast cancer	1.64e-05	0.000165	CcSEcCtD
Floxuridine—Nausea—Methotrexate—breast cancer	1.64e-05	0.000165	CcSEcCtD
Floxuridine—TYMS—Metabolism—MTR—breast cancer	1.64e-05	0.000266	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—CPT1A—breast cancer	1.64e-05	0.000266	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—ABCG2—breast cancer	1.64e-05	0.000266	CbGpPWpGaD
Floxuridine—Diarrhoea—Doxorubicin—breast cancer	1.64e-05	0.000164	CcSEcCtD
Floxuridine—Rash—Epirubicin—breast cancer	1.63e-05	0.000164	CcSEcCtD
Floxuridine—Dermatitis—Epirubicin—breast cancer	1.63e-05	0.000164	CcSEcCtD
Floxuridine—Headache—Epirubicin—breast cancer	1.62e-05	0.000163	CcSEcCtD
Floxuridine—TYMS—Metabolism—HPGDS—breast cancer	1.61e-05	0.000261	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—HBA1—breast cancer	1.6e-05	0.000259	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—RB1—breast cancer	1.59e-05	0.000257	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—CAV1—breast cancer	1.58e-05	0.000257	CbGpPWpGaD
Floxuridine—TYMS—Circadian rythm related genes—IL6—breast cancer	1.57e-05	0.000256	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—GSTT1—breast cancer	1.56e-05	0.000253	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—ACHE—breast cancer	1.56e-05	0.000253	CbGpPWpGaD
Floxuridine—Nausea—Epirubicin—breast cancer	1.54e-05	0.000154	CcSEcCtD
Floxuridine—Vomiting—Doxorubicin—breast cancer	1.52e-05	0.000153	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	1.51e-05	0.000246	CbGpPWpGaD
Floxuridine—Rash—Doxorubicin—breast cancer	1.51e-05	0.000151	CcSEcCtD
Floxuridine—Dermatitis—Doxorubicin—breast cancer	1.51e-05	0.000151	CcSEcCtD
Floxuridine—Headache—Doxorubicin—breast cancer	1.5e-05	0.00015	CcSEcCtD
Floxuridine—TYMS—Metabolism—CYP17A1—breast cancer	1.48e-05	0.00024	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—PTGS1—breast cancer	1.46e-05	0.000237	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—ENO1—breast cancer	1.46e-05	0.000237	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—PIK3CG—breast cancer	1.44e-05	0.000234	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—CYP2D6—breast cancer	1.43e-05	0.000233	CbGpPWpGaD
Floxuridine—Nausea—Doxorubicin—breast cancer	1.42e-05	0.000143	CcSEcCtD
Floxuridine—TYMS—Metabolism—NCOA2—breast cancer	1.41e-05	0.000228	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—CDKN1B—breast cancer	1.38e-05	0.000224	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—FASN—breast cancer	1.36e-05	0.000221	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—BCHE—breast cancer	1.36e-05	0.000221	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—MDM2—breast cancer	1.35e-05	0.000219	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—SLC5A5—breast cancer	1.34e-05	0.000218	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—CCND1—breast cancer	1.32e-05	0.000214	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—SLC2A1—breast cancer	1.3e-05	0.00021	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—NQO1—breast cancer	1.3e-05	0.00021	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—CDKN1A—breast cancer	1.27e-05	0.000207	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—PIK3CD—breast cancer	1.27e-05	0.000206	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—CYP3A4—breast cancer	1.26e-05	0.000205	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—ALB—breast cancer	1.25e-05	0.000203	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—CYP1B1—breast cancer	1.24e-05	0.000202	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—CDKN1B—breast cancer	1.23e-05	0.0002	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—HSP90AA1—breast cancer	1.22e-05	0.000198	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—NOS3—breast cancer	1.2e-05	0.000194	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—NCOA1—breast cancer	1.18e-05	0.000192	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—CCND1—breast cancer	1.18e-05	0.000191	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—STK11—breast cancer	1.17e-05	0.00019	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—CYP19A1—breast cancer	1.17e-05	0.00019	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—CDKN1A—breast cancer	1.14e-05	0.000185	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—PIK3CB—breast cancer	1.1e-05	0.000179	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—PTGS2—breast cancer	1.09e-05	0.000178	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—MAPK3—breast cancer	1.09e-05	0.000176	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—COMT—breast cancer	1.09e-05	0.000176	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—GSTP1—breast cancer	1.08e-05	0.000175	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—HMOX1—breast cancer	1.07e-05	0.000173	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—ITPR1—breast cancer	1.06e-05	0.000173	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—MYC—breast cancer	1.06e-05	0.000172	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—ABCB1—breast cancer	1.02e-05	0.000166	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—PLA2G4A—breast cancer	9.93e-06	0.000161	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—GSTM1—breast cancer	9.93e-06	0.000161	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—NCOR1—breast cancer	9.93e-06	0.000161	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—MAPK3—breast cancer	9.71e-06	0.000158	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—PTEN—breast cancer	9.54e-06	0.000155	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—GPX1—breast cancer	9.51e-06	0.000154	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—MYC—breast cancer	9.44e-06	0.000153	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—CYP1A1—breast cancer	9.41e-06	0.000153	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—ERCC2—breast cancer	9.34e-06	0.000152	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—MTHFR—breast cancer	8.78e-06	0.000143	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—CAV1—breast cancer	8.09e-06	0.000131	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—TP53—breast cancer	7.75e-06	0.000126	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—PIK3CG—breast cancer	7.37e-06	0.00012	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—PIK3CA—breast cancer	6.73e-06	0.000109	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—PIK3CD—breast cancer	6.48e-06	0.000105	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—ALB—breast cancer	6.4e-06	0.000104	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—NOS3—breast cancer	6.12e-06	9.94e-05	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—PIK3CB—breast cancer	5.65e-06	9.17e-05	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—PTGS2—breast cancer	5.6e-06	9.09e-05	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—AKT1—breast cancer	5.5e-06	8.93e-05	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—PTEN—breast cancer	4.88e-06	7.93e-05	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—PIK3CA—breast cancer	3.44e-06	5.59e-05	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—AKT1—breast cancer	2.81e-06	4.57e-05	CbGpPWpGaD
